Share Stryker Stock Price Prediction: 2026–2030 Outlook

Stryker (SYK) stock price prediction

Stryker (SYK) is listed in our stock directory under Medical Devices in the Healthcare sector. Review the available dated company research, financial history and market context below to assess a price outlook.

Earnings research · Company research overview ·

EARNINGS & COMPANY RESEARCH

SYK earnings, valuation & price action

View in calendar ↗
NEXT EXPECTED REPORTFeb 4 2027Time unconfirmed · ET
EPS ESTIMATE5.03
REVENUE ESTIMATE7.7B

Expected dates may change. Estimates use the source’s reporting currency. Quotes and research are snapshots, not live prices.

COMPANY RESEARCH · Healthcare

Stryker Corporation SYK

Medical - Devices · Updated 11/20/2026

Adjusted closing price · USD313.26 Nov 20
264306349392Nov 19May 22Nov 20
Price50-day average200-day average-13.0% in view
VALUATION & EXPECTATIONS
Trailing P/E33.1×
Forward P/E21.1×
Trailing P/S4.5×
Forward P/S4.4×
EPS beat rate75%
Revenue beat rate75%
Positive window25%

EPS beats: 6 of 8 comparable reports. Positive price windows: 2 of 8.

Market caps may be up to 14 days old; prices up to seven days old; ratios and analyst estimates up to fourteen days old. Forward multiples use consensus for the fiscal year ending 2026-12-31, not the next 12 months. Negative or unavailable earnings multiples show “N/A”. Forward ADR multiples are omitted when the currency/share basis is not reconciled.

50-day average295.48
200-day average319.25
RSI (14)52
20-day range291.86 – 339.65
Relative volume0.3×
1-year change-13.0%
Last eight reported earnings for SYK
Report dateEPS estimateEPS actualSurpriseResultRevenue actualPrice window*5 sessions*
Oct 29 20263.553.52-0.8%Miss6.52B-4.0%+10.2%
Jul 30 20263.493.69+5.7%Beat6.59B-7.5%-4.2%
Apr 30 20262.982.60-12.8%Miss6.02B-6.5%-6.6%
Jan 29 20264.404.47+1.6%Beat7.17B+3.3%+1.3%
Oct 30 20253.133.19+1.9%Beat6.06B-3.6%-4.3%
Jul 31 20253.073.13+2.0%Beat6.02B-5.6%-6.0%
May 1 20252.712.84+4.8%Beat5.87B+1.1%+2.3%
Jan 28 20253.874.01+3.6%Beat6.44B-2.2%-1.9%

*Adjusted close before the report date to the first (or fifth) trading close after it. This window can span two sessions and is not an isolated earnings-day return. Figures may be revised by the provider.

Smart Money activity

Recent insider and politician transactions, and disclosed fund positions for SYK.

Get Pro to see what insiders are doing ahead of earnings.

Explore insider trades, fund holdings and politician activity with an active Pro membership.

Checking membership…

SYK earnings previews and market catalysts

Earnings ahead: watch Amazon’s operating profit and Sandisk’s pricing power
2026-10-29 · Ahead of the October 29, 2026 evening earnings reports, watch the quality of Amazon’s profit, Sandisk’s pricing strength and Starbucks’ customer recovery. Intel, healthcare and waste-service results add tests of spending and costs.

Earnings ahead: Amazon’s AI spending and Intel’s recovery face a cash-flow test
2026-10-29 · Amazon and Intel lead the earnings reports expected after close on October 29, 2026. Watch whether cloud and chip growth generate cash, while Starbucks, Mondelez and Republic Services show how demand and costs are shaping profits.

All upcoming earnings catalysts →

02 / FINANCIALS

Stryker financials

Revenue, earnings, cash flow and financial strength in one view.

Reporting currency unconfirmed.

Revenue
Net income
Gross profit
Operating income
EBITDA
Operating cash flow
Capital expenditure
Cash
Total assets
Total liabilities
Shareholder equity
Total debt
Net profit margin
Gross margin
Short interest: days to cover
How to read these financial metrics

Figures use the app’s saved statements for the displayed period, not a trailing-year total. Margins divide profit by revenue; quick ratio uses current assets less inventory divided by current liabilities. Compare dates and currencies before comparing companies.

03 / WHAT COMES NEXT

Stryker event catalysts

Company earnings and scheduled market events that may change expectations.

2027-02-04

SYK earnings

Watch reported results, management’s outlook and the share-price reaction.

See earnings expectations ↑
2026-11-2010:00 AM ET

Consumer sentiment · final

Watch changes in inflation expectations as well as sentiment.

Release schedule ↗Scheduled
2026-11-20Contract-specific cutoff

Monthly options expiration

Check your contract. Position unwinds and hedging can affect trading volume.

Release schedule ↗Scheduled
2026-11-20Time not announced

Russell · membership list update

Track revisions before the effective date; index flows do not guarantee a price rise.

Release schedule ↗Scheduled
2026-11-258:30 AM ET

Durable goods orders

Read core capital-goods orders alongside the headline; aircraft orders can create large swings.

Release schedule ↗Scheduled
2026-11-258:30 AM ET

Initial jobless claims

Use the multiweek trend; a single reading can be noisy. Thanksgiving release moves to Wednesday.

Release schedule ↗Scheduled
2026-11-258:30 AM ET

PCE inflation & consumer spending

Compare core PCE and real spending with expectations to assess inflation alongside demand.

Release schedule ↗Scheduled
2026-11-258:30 AM ET

Q3 GDP · second estimate

Separate consumer demand from inventory and trade effects; revisions can change the growth picture.

Release schedule ↗Scheduled
2026-11-2510:00 AM ET

New home sales

Watch demand, inventories and revisions when assessing homebuilders and rate-sensitive sectors.

Release schedule ↗Scheduled

Dates use U.S. Eastern time and can change. Calendar events provide context; they do not determine the direction of a stock move.

04 / SIDE BY SIDE

Compare SYK with its peers

Medical - Devices · Compare valuation, financial strength and price performance.

Companies with valuation data7
Peer median positive P/E22.8×
SYK P/E33.1×
SYK peer comparison: valuation
CompanyPriceMarket capP/EForward P/EP/SForward P/S
SYKStryker2026-11-20 · USD313.26119.19B33.1×21.1×4.5×4.4×
ATECAlphatec Holdings, Inc.2026-11-20 · USD6.791.1B23.1×1.3×1.3×
CNMDCONMED Corporation2026-11-18 · USD48.011.51B21.0×10.5×1.1×1.1×
ENOVEnovis Corporation2026-11-19 · USD26.381.62B7.1×0.7×0.7×
GMEDGlobus Medical, Inc.2026-11-19 · USD69.239.57B17.4×13.9×3.0×3.1×
IARTIntegra LifeSciences Holdings Corporation2026-11-19 · USD13.571.06B80.9×5.8×0.6×0.6×
MDTMedtronic Plc2026-11-19 · USD100.61128.7B24.7×16.8×3.4×3.3×
SYK33.1×
CNMD21.0×
GMED17.4×
IART80.9×
MDT24.7×

The peer median excludes the selected stock and is based on 4 available positive multiples. P/E median excludes negative or missing earnings multiples. Peer reports can have different fiscal periods and currencies; values are not currency-converted.

SYK stock news and earnings

05 / PEER ANALYSIS

Explore SYK alongside its peers

Medical Devices · 24 companies · Cached market data

Comparison

Compare companies

Tap a bubble to inspect a company, then × to hide it. Undo restores the last company hidden. Bubble area reflects market cap, with a minimum size for visibility.

Price / sales
0.0×03.2×48B6.4×96.01B9.6×144.01BMDT · Medtronic plc. Market cap: 128.7B Price / sales: 3.4×BSX · Boston Scientific Market cap: 66.4B Price / sales: 3.2×EW · Edwards Lifesciences Market cap: 57.43B Price / sales: 8.6×BIO · Bio-Rad Laboratories Market cap: 10.16B Price / sales: 3.9×BRKR · Bruker Market cap: 9.72B Price / sales: 2.8×LIVN · LivaNova Market cap: 5.07B Price / sales: 3.4×IART · Integra LifeSciencess C Market cap: 1.06B Price / sales: 0.6×SYK · Stryker Corporation Market cap: 119.19B Price / sales: 4.5×Hide SYK · Undo restores itMarket cap
SYKStryker Corporation

Market cap: 119.19B
Price / sales: 4.5×

Valuation snapshot: 2026-11-20
8 of 24 companies have both plotted values.

P/S distribution

Trailing price-to-sales multiples · 8 companies

Median P/S3.4×
Middle 50%3.1× to 4.1×
SYK P/S4.5×
SYK
0.6×4.8×

Tap a bar to see the companies in that P/S range. SYK has a higher P/S than 75% of this group.

16 companies excluded from P/S statistics because sales are non-positive or the saved multiple is missing. Statistics include all valid positive values, including those outside the focused chart range.

Companies

Showing 8 of 24 matching companies · Largest market cap first

  • Market cap 185.36BP/E P/S Forward P/E Forward P/S Catalog snapshot
    ↗
  • Market cap 128.7BP/E 24.7×P/S 3.4×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 119.19BP/E 33.1×P/S 4.5×Forward P/E Forward P/S Price snapshot: 2026-11-20
    ↗
  • Market cap 66.4BP/E 19.3×P/S 3.2×Forward P/E Forward P/S Price snapshot: 2026-11-18
    ↗
  • Market cap 57.43BP/E 56.3×P/S 8.6×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 32.95BP/E P/S Forward P/E Forward P/S Catalog snapshot
    ↗
  • Market cap 25.64BP/E P/S Forward P/E Forward P/S Catalog snapshot
    ↗
  • Market cap 22.67BP/E P/S Forward P/E Forward P/S Catalog snapshot
    ↗

Explore industries

Open an industry for its comparison, valuation and companies.

U.S.-listed companies from the app’s catalog. Medians use saved positive P/E values; coverage and snapshot dates vary.

How this comparison works

Uses the saved companies from the same industry and listing market, including SYK, ordered by cached market cap. Company snapshots can have different dates; the web cache may cover fewer metrics and periods than the app.

Periods end at each company’s dated price snapshot. Change compares the latest saved observation with one at or before the selected period’s start. A daily price change uses consecutive saved sessions. Financial data updates quarterly, so short periods may show no change. Missing history and zero starting values are excluded; a negative starting value uses its absolute value as the denominator.

Metrics use saved ratios and percentages. Market caps use the listing market’s reporting currency; underlying financial statements may use different currencies. Circle sizes have a minimum for touch visibility, and an outlined circle indicates a missing market cap. These comparisons describe data, not recommendations or price predictions.

Smart Money activity

Recent insider and politician transactions, and disclosed fund positions for SYK.

Get Pro to see what insiders are doing ahead of earnings.

Explore insider trades, fund holdings and politician activity with an active Pro membership.

Checking membership…

What can move SYK?

A price move may reflect company news, sector conditions or changes in the wider market. Check the timing and primary evidence before attributing a move to one headline.

  • Product demand and revenue growth
  • Research costs and operating margins
  • Regulatory decisions and clinical milestones
  • Competition and patent exposure
  • Cash generation and financing needs

Stryker stock price prediction: 2027 outlook

What could SYK be worth in 2027? A useful prediction starts with dated operating assumptions and a valuation range. This section is a research framework, not a published numerical price target. Use the company’s financial results and guidance to test the assumptions.

SYK stock price prediction for tomorrow

For the next trading session, review company news, overnight market moves, trading volume and technical levels alongside the latest dated quote. A move before the open can reverse during regular trading. On weekends and market holidays, the next trading session is not necessarily tomorrow.

Review SYK news · Review technical analysis

SYK stock outlook for next week

Check whether earnings, company announcements or economic releases fall within the coming week. Compare SYK with industry peers to distinguish company-specific moves from a sector-wide shift. A weekly view should identify the catalyst, the scenario it supports and what would invalidate that view.

Check earnings dates and results · Compare industry performance · Review the market calendar

Stryker stock prediction for next month and the coming months

For December 2026, January 2027 and February 2027, review the earnings calendar, changes in company guidance and the trend in valuation and price. These are research windows, not separate monthly price targets. Reassess the outlook when new results or disclosures change the assumptions.

Compare insider purchases and sales with their disclosure dates and any verified trading-plan status. Unusual options volume can help identify activity worth investigating, but volume alone does not establish a bullish or bearish forecast.

Review available insider and fund activity · Explore earnings research

Stryker stock price prediction for next year: 2027

A longer-term outlook depends on how the business develops and what investors are willing to pay for its earnings or cash flow. Review revenue growth, margins, debt, dilution and capital investment, then test a range of valuation assumptions. A strong business can still underperform if its share price already assumes stronger results.

What to watch for SYK

Product demand and revenue growth; Research costs and operating margins; Regulatory decisions and clinical milestones; Competition and patent exposure; Cash generation and financing needs. Compare changes in these drivers with the assumptions behind any forecast, rather than relying on a target price alone.

2026, 2027, 2028, 2029 and 2030: a longer-term research roadmap

These calendar-year checkpoints describe what to investigate, not calculated share-price forecasts. As a year passes, compare the assumptions with reported results. Later years depend on more uncertain growth, profitability and valuation assumptions.

2026: establish the starting point
Review reported results, the latest dated share price and the valuation already implied by the market.
2027: test company execution
Track product demand and revenue growth against guidance and assess research costs and operating margins as new results become available.
2028: assess durability
Review whether growth can translate into sustainable cash flow, considering regulatory decisions and clinical milestones.
2029: reassess competitive and financial risks
Stress-test the outlook against competition and patent exposure, funding requirements and potential dilution.
2030: evaluate the long-term valuation range
Compare multiple growth and valuation scenarios, including the effect of cash generation and financing needs. More distant horizons require wider uncertainty ranges.

Bull, base and bear scenarios

  • Bull case: operating results exceed the stated assumptions and investors sustain a higher valuation.
  • Base case: revenue, profitability and cash flow broadly follow the assumptions being tested.
  • Bear case: business performance weakens, financing needs rise or the market pays a lower multiple.

Is a 12-month target the same as a 2027 prediction?

No. A rolling 12-month target runs from its publication date; a calendar-year forecast may refer to year-end. Check the analyst or model source, date, currency, earnings definition and horizon. Company guidance describes operating expectations, not a promised share price.

Explore SYK valuation and company research →

Price and valuation

This page does not currently provide a verified live quote. Confirm the price, currency, market session and quote timestamp with your broker before making a decision. Valuation depends on earnings, growth expectations and the risks priced into the shares.

How to assess the next earnings report

Compare reported results with the previous year and with expectations from a dated, identified source. Separate reported earnings from adjusted figures, and read forward guidance and the cash-flow statement.

INDUSTRY COMPARISON

SYK industry peers

Industry unavailable · Oct 16, 2026 · Closing-price performance

No industry peers are available in the current heatmap coverage.